APA (7th ed.) Citation

D, M., O, L., N, M., N, A., H, B., S, N., . . . V, O. (2025). Combining CAR T-Cell Therapy and Nivolumab to Overcome Immune Resistance in THRLBCL: A Case Report. International journal of molecular sciences, 26(19), . https://doi.org/10.3390/ijms26199265

Chicago Style (17th ed.) Citation

D, Munarriz, et al. "Combining CAR T-Cell Therapy and Nivolumab to Overcome Immune Resistance in THRLBCL: A Case Report." International Journal of Molecular Sciences 26, no. 19 (2025). https://doi.org/10.3390/ijms26199265.

MLA (9th ed.) Citation

D, Munarriz, et al. "Combining CAR T-Cell Therapy and Nivolumab to Overcome Immune Resistance in THRLBCL: A Case Report." International Journal of Molecular Sciences, vol. 26, no. 19, 2025, https://doi.org/10.3390/ijms26199265.